• FirefoxInstall the new Firefox »
  •  Dow Down1.54% Nasdaq Down1.11%

    Rexahn Pharmaceuticals, Inc. (RNN)

    -NYSE MKT
    0.75 Down 0.02(2.58%) 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development3,253  3,393  11,992  
    Selling General and Administrative4,689  3,144  4,094  
    Non Recurring -   -   -  
    Others37  42  45  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (7,979) (6,580) (16,131)
    Income from Continuing Operations
    Total Other Income/Expenses Net(1,521)353  4,786  
    Earnings Before Interest And Taxes(9,499)(6,227)(11,345)
    Interest Expense -   -   -  
    Income Before Tax(9,499)(6,227)(11,345)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(9,499)(6,227)(11,345)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (9,499) (6,227) (11,345)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (9,499) (6,227) (11,345)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.